rxstat › Shortages › Clopidogrel

Clopidogrel shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Clopidogrel products are in shortage in Canada (4 of 18 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 10, 2026.
Products affected
4 of 18
In shortage since
Sep 17, 2018
Est. full return
Nov 10, 2026
Reports on file
108
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-CLOPIDOGREL
300MG · TABLET · APOTEX INC
DIN 02398591 · since Jun 9, 2026, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-CLOPIDOGREL
75MG · TABLET · TEVA CANADA LIMITED
DIN 02293161 · since Jun 24, 2026, est. end Nov 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-CLOPIDOGREL
300MG · TABLET · TEVA CANADA LIMITED
DIN 02388065 · since Nov 25, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CLOPIDOGREL
300MG · TABLET · APOTEX INC
DIN 02398591 · since Oct 8, 2025, est. end Apr 17, 2026 · Disruption of the manufacture of the drug.
Active shortage
MAR-CLOPIDOGREL
75MG · TABLET · MARCAN PHARMACEUTICALS INC
DIN 02422255 · since Sep 17, 2018, no end estimate · Other (Please describe in comments)
Resolved
M-CLOPIDOGREL
75MG · TABLET · MANTRA PHARMA INC
DIN 02502283 · ended Feb 10, 2026 · Delay in shipping of the drug.
Resolved
CLOPIDOGREL
75MG · TABLET · SANIS HEALTH INC
DIN 02400553 · ended Feb 2, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-CLOPIDOGREL
75MG · TABLET · APOTEX INC
DIN 02252767 · ended Jan 15, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-CLOPIDOGREL
75MG · TABLET · APOTEX INC
DIN 02252767 · ended Feb 19, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-CLOPIDOGREL
75MG · TABLET · APOTEX INC
DIN 02252767 · ended Feb 19, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-CLOPIDOGREL
75MG · TABLET · APOTEX INC
DIN 02252767 · ended Dec 4, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-CLOPIDOGREL
75MG · TABLET · APOTEX INC
DIN 02252767 · ended Dec 4, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Clopidogrel is currently affected by 4 active shortage reports filed with Health Canada by APOTEX INC, TEVA CANADA LIMITED, MARCAN PHARMACEUTICALS INC.

The reported causes are: disruption of the manufacture of the drug; other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Clopidogrel is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AC).

Recent changes

Common questions

When will Clopidogrel be back in stock in Canada?

The latest manufacturer estimate is Nov 10, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Clopidogrel in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antithrombotic agents)

Widespread shortageNadroparin7 of 8 reported products affectedWidespread shortageTicagrelor2 of 4 reported products affected · est. return Jul 31, 2026Partial shortageBivalirudin1 of 3 reported products affected · est. return Jun 30, 2026Partial shortageDabigatran Etexilate2 of 6 reported products affected · est. return Jun 12, 2026Partial shortageEdoxaban1 of 6 reported products affected · est. return Jul 10, 2026Partial shortageRivaroxaban5 of 18 reported products affected · est. return Nov 30, 2026

All antithrombotic agents shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.